Premium
Genomic study of congenital insensitivity to pain provides new avenues for the development of analgesics
Author(s) -
Wright G.E.B.
Publication year - 2015
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12652
Subject(s) - pharmacogenomics , wright , medicine , library science , family medicine , genealogy , history , computer science , pharmacology , art history
1. Goldberg YP, Pimstone SN, Namdari R et al. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Clin Genet 2012: 82: 367–373. 2. Chong JX, Buckingham KJ, Jhangiani SN et al. The genetic basis of Mendelian phenotypes: discoveries, challenges, and opportunities. Am J Hum Genet 2015: 97: 199–215. 3. Leipold E, Liebmann L, Korenke GC et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat Genet 2013: 45: 1399–1404.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom